Showing 211-220 of 2993 results for "".
PFO Closure for Cryptogenic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/pfo-closure-for-cryptogenic-stroke/30294/Data from three randomized clinical trials offer promising results for the use of patent foramen ovale closure in the treatment of cryptogenic stroke.Inpatient Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/inpatient-headache-treatment/31903/A multidisciplinary approach with scheduled and as needed medications and nonpharmacologic treatments provides best outcomes of inpatient headache care.Emerging Treatments for Tardive Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-treatments-for-tardive-syndrome/32042/Practical approaches and emerging treatments offer novel therapeutic strategies for tardive syndrome.Innovations in Parkinson's Disease: Deep Brain Stimulation and Magnetic Resonance-guided Focused Ultrasound
https://practicalneurology.com/diseases-diagnoses/movement-disorders/innovations-in-parkinsons-disease-deep-brain-stimulation-and-magnetic-resonance-guided-focused-ultrasound/30500/Rapid progress in deep brain stimulation and focused ultrasound offer a glimpse of the future of treatment for Parkinson's disease.Focal Status Epilepticus 9 Years After Brain Abscess
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/focal-status-epilepticus-9-years-after-brain-abscess/31838/Consider high-dose steroids for drug-resistant seizures that may be exacerbated by brain inflammation.Rescue Therapies for Seizures in the Community Setting
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/rescue-therapies-for-seizures-in-the-community-setting/30422/With the majority of seizure emergencies occurring outside a medical setting, there is a great need for effective pre-hospital therapies that absorb fast and administer easily.Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/Managing Symptoms of Anxiety, Panic, Depression, Apathy, and Pseudobulbar Effect in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/managing-symptoms-of-anxiety-panic-depression-apathy-and-pseudobulbar-effect-in-individuals-with-parkinson-disease/37655/Neuropsychiatric symptoms associated with Parkinson disease, including anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment as well as consideration of various treatment options to improve quality of life in this population.Anti-NMDA Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/anti-nmda-receptor-encephalitis/30674/Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.